Holly Tao is a member of the Firm’s Global Antitrust/Competition Group. Her practice focuses on complex litigation in the areas of antitrust and patent law.
She represents global pharmaceutical companies in nationwide, antitrust class-action lawsuits and in licensing and contractual disputes. Her litigation practice also includes cases arising under the Biologics Price Competition and Innovation Act and the Hatch-Waxman Act. She counsels clients on competition-risk issues, including government investigations and patent invalidity and infringement assessments.
Holly is also active in the Firm's pro bono work. She represents individuals and organizations at both trial and appellate courts, and has litigated matters regarding US constitutional rights as well as cases brought under Title VII of the Civil Rights Act and the Individuals with Disabilities Education Act.
